ALMDT Median Technologies

Median Technologies Ranks in Deloitte Technology Fast 500â„¢ EMEA for 2017

Regulatory News:

Median Technologies (Paris:ALMDT), the industry-leading Imaging Phenomics Company®, announced it ranked among the fastest growing technology companies in Europe, the Middle East and Africa (EMEA) on the Deloitte Technology Fast 500™ EMEA list for 2017. Median grew by 428% over the period with increasing demand of the company’s medical imaging contract research services or iCRO.

“We are very proud to have our company appear in this prestigious ranking,” stated Fredrik Brag, CEO at Median Technologies. “Our rapid growth in the analysis and management of medical images for clinical trials has enabled our biopharmaceutical clients to better leverage imaging data – a necessity for bringing new drugs and therapies to the patients who need them,” he added.

Paul Sallomi, Deloitte Global Technology, Media & Entertainment, and Telecommunications, Industry Leader, stated “Congratulations to this year’s Fast 500 EMEA winners on their achievements. As technology continues to transform every aspect of how we live and work, innovative, high-growth companies will continue to be at the forefront of bringing new ideas to the marketplace. I look forward to seeing this year’s winners make a positive impact on our world for years to come.

About Deloitte Global’s 2017 Technology Fast 500 EMEA program

Deloitte Global’s Technology Fast 500™ EMEA program is an objective industry ranking focused on the technology ecosystem. It recognizes technology companies that have achieved the fastest rates of revenue growth in Europe, the Middle East, and Africa (EMEA) during the past four years. The program is supported by Deloitte Global’s Technology Fast 50 initiatives, which rank high-growth technology companies by location or specifically defined geographic area, and are run by Deloitte Global’s Technology, Media & Telecommunications (TMT) industry group. More information on the program is available at www.deloitte.com/fast500emea

Now in its seventeenth year, the Technology Fast 500 program in EMEA included over 18 countries, including Belgium, France, Finland, Germany, Italy, the Netherlands, Turkey and the UK. This year’s winners were selected based on percentage fiscal-year revenue growth from 2013 to 2016.

Sponsors of Deloitte Global’s 2017 Technology Fast 500 EMEA program are Euronext, a pan-European exchange that helps tech companies finance growth and innovative projects through the stock market; Oracle NetSuite, provider of cloud-based financials / Enterprise Resource Planning (ERP), HR and omnichannel commerce software that runs the business of companies in more than 100 countries; and Michael Page, recognized by clients and candidates the world over as the leading specialist consultancy in permanent recruitment, temporary staffing and interim management.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL (also referred to as “Deloitte Global”) and each of its member firms are legally separate and independent entities. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more about our global network of member firms.

About Median Technologies: Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We leverage the power of Imaging Phenomics to provide insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for Patient Care, iSee® for image management in clinical trials and iBiopsy® for imaging phenotyping, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world to quickly and precisely bring new treatments to patients in need, with an eye on reducing overall care costs. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2017-2018. Median Technologies has been awarded the 2017 Tech 40 Label, has joined the EnterNext Tech 40 Index and is a winner of the Deloitte Technology Fast 500 2017 EMEA program. Median is a member of the Bpifrance Excellence Network. For more information: www.mediantechnologies.com

EN
04/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Median Technologies

Median Technologies: 1 director

A director at Median Technologies sold 14,000 shares at 3.161EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Maria Vara
  • Maria Vara

Median Technologies: EUR23.5m capital raise extends runway into Q4 202...

Median Technologies successfully secured a capital raise via ABSA of EUR23.5m in total gross proceeds, priced at EUR1.66 (at ~18% discount to 20-day VWAP). The offering was oversubscribed, surpassing the initial EUR22m target, with 64% backed by existing shareholders, 2% by a public offering in Fra

Maria Vara
  • Maria Vara

Median Technologies: Launch of EUR22m capital increase to unlock EIB f...

Median Technologies has launched a EUR22m capital increase via a public offering of shares with warrants (ABSA), priced at EUR1.66 (at ~18% discount to 20-day VWAP), with 78% of the deal already secured via existing and new investors. The raise aimed to i) meet the drawing conditions of the Tranche

Maria Vara
  • Maria Vara

Median Technologies: EIB loan signed, tied to equity raise and debt re...

Friday post-market, Median announced the final sign of the EIB loan agreement of EUR37.5m, which has been structured in three tranches (EUR19m, EUR8.5m, EUR10m) and with several key conditions being set to access the first one. These include i) a capital increase of at least EUR16m (including issua

Maria Vara
  • Maria Vara

Median Technologies: CE mark filing keep eyonis on track, US launch be...

Yesterday post-market, Median announced that it has submitted the Class IIb CE marking filing for eyonis LCS, just a month after the FDA 510(k) submission, precisely sticking to the company's timeline guidance. Our confidence in a positive outcome remains high, as both submissions are underpinned b

ResearchPool Subscriptions

Get the most out of your insights

Get in touch